Answer
During treatment with ALTUVOCT 750 IU (efanesoctocog alfa), using SynthASil in a one-stage clotting assay gives approximately 30% lower measured plasma factor VIII activity than using Actin-FSL, according to a field study.
Sources for this answer
- ALTUVOCT 750 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked